Wyden Renews Call for PBM Reforms Needed to Lower Drug Prices and Increase Access Following New FTC Report
Interim Report from the Federal Trade Commission Underscores Need to Pass Finance Committee Legislation to Make Pharmacy Benefit Managers Accountable to Americans Washington, D.C. – Senate Finance Committee Chair Ron Wyden, D-Ore., today issued a statement after the […]